Filtered By:
Condition: Hypertension
Management: Insurers

This page shows you your search results in order of date.

Order by Relevance | Date

Total 5 results found since Jan 2013.

Maternal and neonatal complications in women with congenital heart disease: a nationwide analysis
ConclusionsThis population-based study illustrates a reassuringly low maternal mortality rate in a highly developed healthcare system. Nevertheless, maternal morbidity and neonatal morbidity/mortality were significantly increased in women with ACHD and their offspring compared to non-ACHD controls highlighting the need of specialized care and pre-pregnancy counselling.
Source: European Heart Journal - October 12, 2021 Category: Cardiology Source Type: research

Depression Has Spiked By 33% In the Last Five Years, a New Report Says
Diagnoses of clinical depression — also known as major depression — have risen by 33% since 2013, according to a new report from health insurer Blue Cross Blue Shield. The report, which was based on insurance claims filed by 41 million privately insured Blue Cross Blue Shield members, calls depression the “second most impactful condition on overall health for commercially insured Americans,” behind only high blood pressure. That’s because people with depression also tend to have other health issues, such as chronic illnesses and substance abuse, and as a result may have more significant health...
Source: TIME: Health - May 10, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthytime Mental Health/Psychology onetime Source Type: news

Modafinil for the Improvement of Patient Outcomes Following Traumatic Brain Injury
Conclusion. Modafinil is a central nervous system stimulant with well-established effectiveness in the treatment of narcolepsy and shift-work sleep disorder. There is conflicting evidence about the benefits of modafinil in the treatment of fatigue and EDS secondary to TBI. One randomized, controlled study states that modafinil does not significantly improve patient wakefulness, while another concludes that modafinil corrects EDS but not fatigue. An observational study provides evidence that modafinil increases alertness in fatigued patients with past medical history of brainstem diencephalic stroke or multiple sclerosis. ...
Source: Innovations in Clinical Neuroscience - April 1, 2018 Category: Neuroscience Authors: ICNS Online Editor Tags: Current Issue Review excessive daytime sleep fatigue head injury modafinil stroke TBI traumatic brain injury Source Type: research

Abstract 137: Clinical Outcomes After Cardiac Stress Testing Among U.S. Patients Younger Than 65, 2006-2012 Session Title: Poster Session I
Conclusion: The percentage of commercially insured U.S. patients who had an AMI or revascularization event within 1 year of stress testing was small. In the lowest risk quintile, the a priori prevalence of coronary disease risk factors was low, and the rates of subsequent AMI and revascularization was extremely low, raising questions about the value of stress testing in this subgroup.
Source: Circulation: Cardiovascular Quality and Outcomes - March 31, 2017 Category: Cardiology Authors: Kini, V., Dayoub, E., Marzec, L., Dickinson, M., Wynia, M., Masoudi, F., Ho, M., Groeneveld, P. Tags: Session Title: Poster Session I Source Type: research

Modeled Health and Economic Impact of Team-Based Care for Hypertension
Conclusions Nationwide adoption of team-based care for uncontrolled hypertension could have sizable effects in reducing CVD burden. Based on the study’s assumptions, the policy would be cost saving from the perspective of Medicare and may prove to be cost effective from other payers’ perspectives. Expected net cost savings for Medicare would more than offset expected net costs for all other insurers.
Source: American Journal of Preventive Medicine - April 18, 2016 Category: Global & Universal Source Type: research